Optical coherence tomography angiography in age-related macular degeneration: The game changer

Abstract

Optical coherence tomography angiography is one of the biggest advances in ophthalmic imaging. It enables a depth-resolved assessment of the retinal and choroidal blood flow, far exceeding the levels of detail commonly obtained with dye angiographies. One of the first applications of optical coherence tomography angiography was in detecting the presence of choroidal neovascularization in age-related macular degeneration and establishing its position in relation to the retinal pigmented epithelium and Bruch’s membrane, and thereby classifying the CNV as type 1, type 2, type 3, or mixed lesions. Optical coherence tomography angiograms, due to the longer wavelength used by optical coherence tomography, showed a more distinct choroidal neovascularization vascular pattern than fluorescein angiography, since there is less suffering from light scattering or is less obscured by overlying subretinal hemorrhages or exudation. Qualitative and quantitative assessments of optical coherence tomography angiography findings in exudative and nonexudative age-related macular degeneration have been largely investigated within the past 3 years both in clinical and experimental settings. This review constitutes an up-to-date of all the potential applications of optical coherence tomography angiography in age-related macular degeneration in order to better understand how to translate its theoretical usefulness into the current clinical practice.

Keywords

Optical coherence tomography angiography age-related macular degeneration choroidal neovascularization exudative age-related macular degeneration

Get full access to this article

View all access options for this article.

References

Bressler

NM.

Age-related macular degeneration is the leading cause of blindness. JAMA 2004; 291: 1900–1901.

Pascolini

Mariotti

Pokharel

et al . 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol 2004; 11: 67–115.

Keane

Patel

Liakopoulos

et al . Evaluation of age-related macular degeneration with optical coherence tomography. Surv Ophthalmol 2012; 57: 389–414.

Regatieri

Branchini

Duker

JS.

The role of spectral-domain OCT in the diagnosis and management of neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2011; 42: S56–S66.

Bird

Bressler

et al . An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367–374.

Ambati

Yoo

et al . Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003; 48: 257–293.

Jager

Mieler

Miller

JW.

Age-related macular degeneration. N Engl J Med 2008; 358: 2606–2617.

Zarbin

MA.

Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004; 122: 598–614.

Wong

Chakravarthy

et al . The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Opthamalogy 2008; 115(1): 116–126.

10.

Hogg

Chakravarthy

Visual function and dysfunction in early and late age-related maculopathy. Prog Retin Eye Res 2006; 25: 249–276.

11.

De Jong

PTVM

. Age-related macular degeneration. N Engl J Med 2006; 355: 1474–1485.

12.

Holz

Pauleikhoff

Klein

et al . Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 2004; 137: 504–510.

13.

Ferris

III Fine

Hyman

Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984; 102: 1640–1642.

14.

Spaide

RF.

Optical coherence tomography angiography signs of vascular abnormalization with antiangiogenic therapy for choroidal neovascularization. Am J Ophthalmol 2015; 160(1): 6–16.

15.

Yannuzzi

Negrao

Lida

et al . Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21: 416–434.

16.

De Carlo

Bonini Filho

Chin

et al . Spectral-domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology 2015; 122: 1228–1238.

17.

Gower

Cassard

et al . Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC study. Ophthalmology 2012; 119: 771–778.

18.

Kotsolis

Killian

Ladas

ID.

Fluorescein angiography and optical coherence tomography concordance for choroidal neovascularization in multifocal choroiditis. Br J Ophthalmol 2010; 94: 1506–1508.

19.

DV.

Detection of new-onset choroidal neovascularization. Curr Opin Ophthalmol 2013; 24: 224–227.

20.

Sulzbacher

Kiss

Munk

et al . Diagnostic evaluation of type 2 (classic) choroidal neovascularization: optical coherence tomography, indocyanine green angiography, and fluorescein angiography. Am J Ophthalmol 2011; 152(5): 799–806.e1.

21.

Stanga

Lim

Hamilton

Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology 2003; 110: 15–21.

22.

Lopez-Saez

Ordoqui

Tornero

et al . Fluorescein-induced allergic reaction. Ann Allergy Asthma Immunol 1998; 81: 428–430.

23.

Yannuzzi

Rohrer

Tindel

et al . Fluorescein angiography complication survey. Ophthalmology 1986; 93(5): 611–617.

24.

Huang

Swanson

Lin

et al . Optical coherence tomography. Science 1991; 254: 1178–1181.

25.

Drexler

Fujimoto

JG.

State-of-the-art retinal optical coherence tomography. Prog Retin Eye Res 2008; 27: 45–88.

26.

Jia

Tan

Tokayer

et al . Split-spectrum amplitude decorrelation angiography with optical coherence tomography. Opt Express 2012; 20(4): 4710–4725.

27.

Choi

Moult

Waheed

et al . Ultrahigh-speed, swept source optical coherence tomography angiography in nonexudative age related macular degeneration with geographic atrophy. Ophthalmology 2015; 122(12): 2532–2544.

28.

Moult

Choi

Waheed

et al . Ultrahigh-speed swept-source OCT angiography in exudative AMD. Ophthalmic Surg Lasers Imaging Retina 2014; 45(6): 496–505.

29.

Tokayer

Jia

Dhalla

AH.

Blood flow velocity quantification using split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Biomed Opt Express 2013; 4: 1909–1924.

30.

Kuehlewein

Sadda

Sarraf

OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy. Eye 2015; 29(7): 932–935.

31.

Kuehlewein

Bansal

Lenis

et al . Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration. Am J Ophthalmol 2015; 160(4): 739–748.e2.

32.

Naysan

Dansingani

Balaratnasingam

et al . Type 1 neovascularization with polypoidal lesions complicating dome shaped macula. Int J Retina Vitreous 2015; 1: 8.

33.

Dansingani

Balaratnasingam

Klufas

et al . Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol 2015; 160(6): 1243–1254.e2.

34.

Potsaid

Baumann

Huang

et al . Ultrahigh speed 1050nm swept source/Fourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second. Opt Express 2010; 18: 20029–20048.

35.

Jia

Bailey

Wilson

et al . Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology 2014; 121(7): 1435–1444.

36.

Coscas

Lupidi

Coscas

et al . Optical coherence tomography angiography versus traditional multimodal imaging in assessing the activity of exudative age-related macular degeneration: a new diagnostic challenge. Retina 2015; 35(11): 2219–2228.

37.

Sulzbacher

Pollreisz

Kaider

et al . Identification and clinical role of choroidal neovascularization characteristics based on optical coherence tomography angiography. Acta Ophthalmol 2017; 95(4): 414–420.

38.

Al-Sheikh

Iafe

Phasukkijwatana

et al . Biomarkers of neovascular activity in age-related macular degeneration using OCT angiography. Retina 2018; 38(2): 220–230.

39.

Faridi

Jia

Sensitivity and specificity of OCT angiography to detect choroidal neovascularization. Ophthalmol Retina 2017; 1(4): 294–303.

40.

McClintic

Kim

Fingler

et al . Detection of pigment epithelial detachment vascularization in age-related macular degeneration using phase-variance OCT angiography. Clin Ophthalmol 2015; 9: 1299–1305.

41.

Veronese

Maiolo

Morara

et al . Optical coherence tomography angiography to assess pigment epithelial detachment. Retina 2016; 36(3): 645–650.

42.

Palejwala

Jia

Gao

et al . Detection of nonexudative choroidal neovascularization in age-related macular degeneration with optical coherence tomography angiography. Retina 2015; 35: 2204–2211.

43.

Freund

Zweifel

Engelbert

Do we need a new classification for choroidal neovascularization in age-related macular degeneration?

Retina 2010; 30: 1333–1349.

44.

El Ameen

Cohen

Semoun

et al . Type 2 neovascularization secondary to age-related macular degeneration imaged by optical coherence tomography angiography. Retina 2015; 35: 2212–2218.

45.

Coscas

Lupidi

Coscas

et al . Optical coherence tomography angiography during follow-up: qualitative and quantitative analysis of mixed type I and II choroidal neovascularization after vascular endothelial growth factor trap therapy. Ophthalmic Research 2015; 54(2): 57–63.

46.

Dansingani

Tan

Gilan

et al . Subretinal hyperreflective material imaged with optical coherence tomography angiography. Am J Ophthalmol 2016; 169: 235–248.

47.

Dansingani

Naysan

Freund

KB.

En face OCT angiography demonstrates flow in early type 3 neovascularization (retinal angiomatous proliferation). Eye 2015; 29(5): 703–706.

48.

Phasukkijwatana

Tan

Chen

et al . Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy. Br J Ophthalmol 2017; 101(5): 597–602.

49.

Miere

Querques

Semoun

et al . Optical coherence tomography angiography in early type 3 neovascularization. Retina 2015; 35: 2236–2241.

50.

Kuehlewein

Dansingani

de Carlo

et al . Optical coherence tomography angiography of type 3 neovascularization secondary to age-related macular degeneration. Retina 2015; 35: 2229–2235.

51.

Inoue

Balaratnasingam

Freund

KB.

Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization. Retina 2015; 35: 2265–2274.

52.

Chan

Wang

et al . Polypoidal choroidal vasculopathy upon optical coherence tomography angiography. Retina 2018; 38 (6): 1187–1194.

53.

Miura

Muramatsu

Hong

et al . Noninvasive vascular imaging of polypoidal choroidal vasculopathy by Doppler optical coherence tomography. Invest Ophthalmol Vis Sci 2015; 56: 3179–3186.

54.

Srour

Querques

Semoun

et al . Optical coherence tomography angiography characteristics of polypoidal choroidal vasculopathy. Br J Ophthalmol 2016; 100(11): 1489–1493.

55.

McLeod

Grebe

Bhutto

et al . Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 2009; 50: 4982–4991.

56.

Cicinelli

Rabiolo

Marchese

et al . Choroid morphometric analysis in non-neovascular age-related macular degeneration by means of optical coherence tomography angiography. Br J Ophthalmol 2017; 101(9): 1193–1200.

57.

Borrelli

Uji

Sarraf

Alterations in the choriocapillaris in intermediate age-related macular degeneration. Invest Ophthalmol Vis Sci 2017; 58: 4792–4798.

58.

Muakkassa

Chin

de Carlo

et al . Characterizing the effect of anti-vascular endothelial growth factor therapy on treatment-naive choroidal neovascularization using optical coherence tomography angiography. Retina 2015; 35(11): 2252–2259.

59.

Sarks

Killingsworth

MC.

Evolution of geographic atrophy of the retinal-pigment epithelium. Eye 1988; 2: 552–577.

60.

Bhutto

Lutty

Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex. Mol Aspects Med 2012; 33(4): 295–317.

61.

Sunness

Gonzalez-Baron

Bressler

et al . The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology 1999; 106: 910–919.

62.

Capuano

Miere

Querques

et al . Treatment-naïve quiescent choroidal neovascularization in geographic atrophy secondary to nonexudative age-related macular degeneration 2017; 182: 45–55.

63.

Nesper

Lutty

Fawzi

AA.

Residual choroidal vessels in atrophy can masquerade as choroidal neovascularization on optical coherence tomography angiography: introducing a clinical and software approach. Retina. Epub ahead of print 20 October 2017. DOI: 10.1097/IAE.0000000000001863.

64.

Sarks

Killingsworth

MC.

Morphology of early choroidal neovascularisation in age-related macular degeneration: correlation with activity. Eye 1997; 11(4): 515–522.

65.

Benjamin

Hemo

Keshet

A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998; 125(9): 1591–1598.

66.

Lumbroso

Rispoli

Savastano

MC.

Longitudinal Optical Coherence Tomography–Angiography Study of type 2 naive choroidal neovascularization early response after treatment. Retina 2015; 35: 2242–2251.

67.

Huang

Jia

Rispoli

et al . Optical coherence tomography angiography of time course of choroidal neovascularization in response to anti-angiogenic treatment. Retina 2015; 35: 2260–2264.

68.

Miere

Querques

Semoun

et al . Optical coherence tomography angiography changes in early type 3 neovascularization after anti-vascular endothelial growth factor treatment. Retina 2017; 37(10): 1873�1879.